Sasta ParchaWahi dawai. Sahi daam.

Salt / ingredient

Dapagliflozin 10mg + Sitagliptin 50mg

Controls sugar, protects heart/kidney + Controls blood sugar

MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.

More about this medicine

Reference information

About Dapagliflozin

Source: OpenFDA

This information is from US FDA labels, for reference only. Always follow your doctor's advice.

Common side effects
  • female genital mycotic infections
  • nasopharyngitis
  • urinary tract infections
  • to report suspected adverse reactions
  • contact zydus pharmaceuticals (usa) inc
Safety advice
  • May affect the kidneys. Tell your doctor if you have kidney problems.
  • Avoid or limit alcohol while taking this medicine.
  • May cause low blood sugar. Watch for symptoms like shakiness, sweating, confusion.
  • May affect the liver. Tell your doctor if you have liver problems.
  • Stop use and seek emergency help if you have signs of a severe allergic reaction.
Uses
  • dapagliflozin) is indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.
  • • To reduce the risk of CV death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure.
  • • To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors.
  • • As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
  • Limitations of Use • is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus .
How to take
  • • Assess renal function prior to initiation and then as clinically indicated.
  • Assess volume status and correct volume depletion before initiating.
  • (2.1) • To improve glycemic control, the recommended starting dosage is 5 mg orally once daily.
  • Dosage can be increased to 10 mg orally once daily for additional glycemic control.
  • (2.2) • For all other indications, the recommended dosage is 10 mg orally once daily.

Frequently Asked Questions about Dapagliflozin 10mg + Sitagliptin 50mg

What is the price of Dapagliflozin 10mg + Sitagliptin 50mg in India?

The price of Dapagliflozin 10mg + Sitagliptin 50mg in India depends on the manufacturer and channel. Official Government Jan Aushadhi generic rates start at ₹2.81 per unit.Private commercial brands vary from low-cost options to higher-priced branded formulations.

Is a Government Jan Aushadhi generic available for Dapagliflozin 10mg + Sitagliptin 50mg?

Dapagliflozin 10mg + Sitagliptin 50mg is listed under PMBI Jan Aushadhi (PMBI Code 2521) at ₹28.13 per pack.

How to find lower-cost substitutes for Dapagliflozin 10mg + Sitagliptin 50mg?

Search the active salt formulation (Dapagliflozin 10mg + Sitagliptin 50mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.